TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF

Brain. 2015 Dec;138(Pt 12):3610-22. doi: 10.1093/brain/awv297. Epub 2015 Oct 21.

Abstract

Currently there is no neuroprotective or neurorestorative therapy for Parkinson's disease. Here we report that transient receptor potential vanilloid 1 (TRPV1) on astrocytes mediates endogenous production of ciliary neurotrophic factor (CNTF), which prevents the active degeneration of dopamine neurons and leads to behavioural recovery through CNTF receptor alpha (CNTFRα) on nigral dopamine neurons in both the MPP(+)-lesioned or adeno-associated virus α-synuclein rat models of Parkinson's disease. Western blot and immunohistochemical analysis of human post-mortem substantia nigra from Parkinson's disease suggests that this endogenous neuroprotective system (TRPV1 and CNTF on astrocytes, and CNTFRα on dopamine neurons) might have relevance to human Parkinson's disease. Our results suggest that activation of astrocytic TRPV1 activates endogenous neuroprotective machinery in vivo and that it is a novel therapeutic target for the treatment of Parkinson's disease.

Keywords: Parkinson’s disease; TRPV1; astrocyte; ciliary neurotrophic factor (CNTF); dopamine neurons.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism*
  • Ciliary Neurotrophic Factor / metabolism*
  • Ciliary Neurotrophic Factor Receptor alpha Subunit / metabolism
  • Disease Models, Animal
  • Dopaminergic Neurons / metabolism*
  • Dopaminergic Neurons / pathology
  • Female
  • Humans
  • Nerve Regeneration
  • Neuroprotection*
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology*
  • Parkinson Disease / physiopathology
  • Rats
  • Substantia Nigra / cytology
  • Substantia Nigra / metabolism*
  • Substantia Nigra / pathology
  • TRPV Cation Channels / metabolism

Substances

  • Ciliary Neurotrophic Factor
  • Ciliary Neurotrophic Factor Receptor alpha Subunit
  • TRPV Cation Channels
  • TRPV1 receptor